Literature DB >> 6345459

Creutzfeld-Jakob disease: clinical, EEG and neuropathological findings in a cluster of eleven patients.

A Lechi, F Tedeschi, D Mancia, V Pietrini, F Tagliavini, M G Terzano, G Trabattoni.   

Abstract

10 of 11 Creutzfeld-Jakob disease patients were seen between February 1975 and November 1979. Whilst the clinical and EEG findings were uniform, the neuropathological changes were not: astrogliosis was always diffuse and widespread but the other typical changes (neuronal loss and spongiosis) varied greatly both in degree and location.

Entities:  

Mesh:

Year:  1983        PMID: 6345459     DOI: 10.1007/bf02043437

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  48 in total

1.  Epidemiology of Creutzfeldt-Jakob disease in England and Wales.

Authors:  W B Matthews
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-03       Impact factor: 10.154

2.  [Clinical aspects & neuropathology of subacute presenile spongiform atrophy with dyskinetic terminal stage].

Authors:  H JACOB; W EICKE; H ORTHNER
Journal:  Dtsch Z Nervenheilkd       Date:  1958

3.  A form of subacute encephalopathy of uncertain aetiology.

Authors:  S NEVIN; W H McMENEMEY
Journal:  Proc R Soc Med       Date:  1958-07

4.  [Diffuse atrophic degenerative process, predominantly of the thalamus and corpus striatum; variable extrapyramidal and psychic semeiology; subacute evolution with terminal dementia].

Authors:  Y POURSINES; J BOUDOURESQUES; J ROGER
Journal:  Rev Neurol (Paris)       Date:  1953       Impact factor: 2.607

5.  Rapidly progressive cerebral degeneration (subacute vascular encephalopathy) with mental disorder, focal disturbances, and myoclonic epilepsy.

Authors:  D P JONES; S NEVIN
Journal:  J Neurol Neurosurg Psychiatry       Date:  1954-05       Impact factor: 10.154

6.  Creutzfeldt-Jakob disease treated with amantidine. A report of two cases.

Authors:  W L Sanders; T L Dunn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-08       Impact factor: 10.154

7.  Creutzfeldt-Jakob disease: further similarities with kuru.

Authors:  H Adams; E Beck; A M Shenkin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-02       Impact factor: 10.154

8.  Status spongiosus in Jakob-Creutzfeldt disease. Electron microscopic study of a cortical biopsy.

Authors:  A Bignami; L S Forno
Journal:  Brain       Date:  1970       Impact factor: 13.501

9.  Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice.

Authors:  W F Blakemore
Journal:  J Neurocytol       Date:  1972-12

10.  Cellular sensitization in kuru, Jakob-Creutzfeldt disease and multiple sclerosis: with a note on the biohazards of slow infection work.

Authors:  E J Field; B K Shenton
Journal:  Acta Neurol Scand       Date:  1975-04       Impact factor: 3.209

View more
  5 in total

1.  Considerations on a group of 13 patients with Creutzfeldt-Jakob disease in the region of Parma (Italy)

Authors:  G Trabattoni; A Lechi; L Bettoni; G Macchi; P Brown
Journal:  Eur J Epidemiol       Date:  1990-09       Impact factor: 8.082

2.  A retrospective study of Creutzfeldt-Jakob disease in Italy (1972-1986).

Authors:  C Masullo; M Pocchiari; G Neri; P Casaccia; A Iavarone; A Ladogana; G Macchi
Journal:  Eur J Epidemiol       Date:  1988-12       Impact factor: 8.082

3.  Temporal evolution of electroencephalographic abnormalities in Creutzfeldt-Jakob disease.

Authors:  G K Schlenska; G F Walter
Journal:  J Neurol       Date:  1989-12       Impact factor: 4.849

4.  Early MRI findings in Creutzfeldt-Jakob disease.

Authors:  M Onofrj; T Fulgente; D Gambi; G Macchi
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

5.  Epidemiologic implications of Creutzfeldt-Jakob disease in a 19 year-old girl.

Authors:  P Brown; F Cathala; R Labauge; M Pages; J C Alary; H Baron
Journal:  Eur J Epidemiol       Date:  1985-03       Impact factor: 8.082

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.